Evidence map›Paper›PMID 42589628›Full record

ArticleInternational journal of molecular sciences2026

Molecular Pharmacological Characterization of Dicentrine Isolated from

Aroonchai Saiai, Sirinya Moakmamern, Lapamas Rueankum, Wenxian Yin, Singkome Tima, Siriporn Okonogi, Sawitree Chiampanichayakul, Songyot Anuchapreeda

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aroonchai SaiaiDepartment of Chemistry, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-0155-9952
Sirinya MoakmamernDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Lapamas RueankumDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Wenxian YinDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-2586-4545
Singkome TimaDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0002-3072-3715
Siriporn OkonogiCenter of Excellence in Pharmaceutical Nanotechnology, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-6077-5017
Sawitree ChiampanichayakulDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.
Songyot AnuchapreedaDepartment of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-7259-4694

Funding

Fundamental Fund 2568 207563/R68EX00173
6 · The paper itself

Abstract

Lymphoma remains a major hematological malignancy associated with treatment resistance and systemic toxicity, highlighting the need for novel anticancer agents derived from natural products. In this study, dicentrine (

Indexed as

Antineoplastic Agents, PhytogenicAporphinesLymphomaStephaniaApoptosisCell Line, TumorCell ProliferationHumansMolecular Docking SimulationPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktSignal TransductionAntineoplastic Agents, PhytogenicAporphinesdicentrinePhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktapoptosiscancerc-MycdicentrinelymphomaPI3K/Akt signalingStephania venosa

Identifiers

PMID42589628
PMCPMC13466670

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.